These studies in a novel, relevant monkey model suggest that treatment of dry eye with PACAP-27 may be beneficial because of its stimulating effect on TgN neurite outgrowth to the cornea and because PACAP-27 stimulates tear protein secretion from the lacrimal gland. This evidence concerns the gene TG and dry eye syndrome.